Liver metastasis from rectal cancer occurs with a five-year survival rate of about 42% for patients who are resectable; 9% for those who are not surgically resectable. Rectal cancer is a common malignant tumor of gastrointestinal tract, and the occurrence of the disease is related to many factors such as heredity and gene mutation. When the disease progresses to the advanced stage, distant metastasis often occurs, such as liver metastasis, at this time, patients may have clinical manifestations such as discomfort in liver area, nausea and vomiting, jaundice, hypoalbuminemia and so on. For this period of time has the opportunity of surgery, often feasible surgical resection treatment, and then supplemented with radiotherapy, chemotherapy and other therapies; also through intravenous infusion of albumin and other methods of symptomatic treatment. After aggressive treatment, the five-year survival rate for patients with a chance of surgery is about 42%; conversely, it is about 9%.